Transforming Cancer Treatment with Precision Medicine
Special | 51m 33s
Mark Burkard, co-director of the Precision Medicine Molecular Tumor Board at UW-Madison, discusses targeted cancer treatments based on genetic markers. Burkard highlights the statewide initiative to provide access to common and rare cancer medications at no cost to the patient or the physician.
Aired: 05/22/19Video has closed captioning.
Problems Playing Video?
University Place is made possible by the Corporation for Public Broadcasting.